Introducing Hyosung’s Cash Management Solution for the Cannabis Industry

(Irving, TX) February 10, 2021 – As the cannabis industry continues to grow across North America, cannabis business owners and family-owned cannabis shops are looking for new ways to tackle one of the biggest challenges that they are facing in this cash-only business. How can they keep their cash safe, secure and easily transferable on a daily basis? Nowadays, many cannabis business owners store their cash in safes behind their counter or use even less secure methods to protect their hard-earned money. In fact, in some cases, they just load stacks of cash in a car and store it at home or an offsite depository. Clearly, there are significant risks associated with this method. Also, many dispensary owners utilize their cash on hand to pay their vendors directly at the counter. This leads to significant increase in shrinkage and employee theft. There was a case in CA in 2020, in which more than $1M was lost due to employee theft at a relatively small dispensary chain.

Fortunately, these are all problems for which the largest ATM company in the U.S. has been providing solutions for many years. Hyosung America has been solving cash handling problems for businesses and banking institutions for over two decades. If you’ve ever withdrawn cash from a convenience store or one of the top five banks in the U.S., chances are you’ve interacted with one of Hyosung’s more than 100,000 ATMs. These machines are placed in convenient locations all across North America and have revolutionized the way people access cash. Over the decades, Hyosung has continued to reimagine the way people interact with cash and has adapted new solutions for new industries, such as the rapidly growing cannabis industry.

“In the ever-evolving cannabis industry, it is not enough to simply run the business. Utilizing these products from our world-class engineering team, you can change the business and significant value for the owner, budtender, customer, and vendor. Cash recycling is a simple but significant contribution to a dynamic growth industry’s bottom line,” said Marvin Bowers, Associate Vice President, Retail Sales.

Hyosung’s Retail Cash Recyclers (RCRs) are a ready solution for the many cash handling problems dispensary owners must face every day. RCRs make it possible for any cash-only business to run smoothly, quickly and securely. RCRs work by authenticating incoming bank notes and securely storing the cash in an internal vault. This allows bud tenders and other authorized employees to insert stacks of cash into the machine and never have to hand-count money again. This saves hours and hours of flipping through wadded notes. It also allows for the payment of vendors through two-party authentication codes so that all withdrawals are tracked and employee theft is minimized. It makes cash till generation and end of day settlement extremely easy and can add a substantial degree of safety and efficiency to an otherwise cumbersome and risky process.

To learn more about our Cash Management Solutions contact a Hyosung Sales Representative at sales@nhausa.com or click here to visit our website here.

####

About Hyosung America:
Hyosung America is the US subsidiary of Hyosung, Inc., a global leader in providing ATMs, TCRs and software solutions to the retail off-premises and financial institution markets. Since entering the North American market in 1998, Hyosung has been the fastest growing ATM company in North America and the leading provider of recycling branch transformation solutions. Hyosung is headquartered in Irving, Texas, and provides research and development support in its Global Software Center in Dayton, Ohio.

CONTACT:
Sharon Shaw (Senior Director of Marketing – Hyosung)
(469) 676-1199
sharon.shaw@nhausa.com

End


Colorado Cannabis Sales Exceed $2 Billion in 2020

Colorado cannabis sales totaled $2.19 billion in 2020, the highest annual total since the state passed the reforms in 2014, according to Department of Revenue data outlined by the Colorado Sun. In 2019, Colorado sold $1.75 billion worth of cannabis products.

In all, the state has sold $10 billion in cannabis in the six years following the reforms – including estimated 2021 sales – translating to $1.63 billion in cannabis-derived taxes and fees. Customers are charged a 2.9% sales tax, along with a 15% cannabis retail sales tax, and municipalities can add local sales taxes that are sometimes more than 20%. The state also imposes a 15% excise tax on wholesale sales or transfers of retail cannabis and license and application fees.

Truman Bradley, executive director of the Marijuana Industry Group, told the Sun that the $10 billion total “is incredible and unsurprising at the same time” adding that the industry “has partnered with regulators to do things the right way.”

Under the state’s adult-use law, 90 percent or $40 million – whichever is greater – of the excise tax on wholesale retail cannabis is used for the Build Excellent Schools Today program. According to the state Department of Education, the state has dispersed $40 million each year from 2016 to 2020. Of the 15% special tax on retail sales, 12.59 percent is diverted to the Public School Fund which is distributed to all of the state’s districts.

According to a Leafly report, from 2019 to 2020, Colorado experienced a 22% year-over-year flower price increase per pound to $1,495.18 and a 7% increase in concentrate pricing to $15 per gram.

End


Report: Ohio’s Medical Cannabis Program Is Falling Short

During the pandemic last year, Ohio quadrupled its 2019 medical cannabis sales, according to a Crain’s Cleveland Business report. However, the report claims the total is still far from the state’s potential and highlights issues such as lacking dispensaries, minimal qualifying conditions, and high retail costs as the main reasons why Ohio’s medical cannabis system has felt so lackluster.

For a state with a population of over 11 million people, Ohio only has 54 licensed dispensaries, according to the Ohio Medical Marijuana Control Program.

In a survey conducted in the fall of 2020, 58.4 percent of patients and caregivers in Ohio said the state’s medical cannabis prices are too high, Cleveland.com reports. The high prices were attributed to COVID-19 hoarding behaviors, with long lines at dispensaries kicking off alongside the pandemic last spring.

Despite high prices, the cost of medical cannabis in Ohio is actually fairly average when compared to other Midwest states like Michigan and Illinois, according to Greg McIlvaine of the Ohio Department of Commerce.

“We’re kind of right there in the middle between Michigan and Illinois. We would hope to expect as our market matures, and we continue to get cultivators online and … products, that our prices will start to decline even further from about the $300 per ounce to something closer to $265 per ounce, as in Michigan.” McIlvaine, via Cleveland.com

Ohio’s medical cannabis program currently allows for 22 qualifying conditions — the state added cachexia last year but warned that Autism and other conditions would not be reconsidered until new research was submitted.

End


Washington Social Equity Task Force Makes Legislative Recommendations

Washington state’s Task Force on Social Equity made two motions in their latest meeting on January 26. In their suggestions, they dictate that equity prioritization be based on race rather than location, and to include current I-502 licensees who fit equity criteria in their recent meeting. In response to these motions, state Sen. Rebecca Saldaña introduced SB 5388 on January 29 and state representative Melanie Morgan introduced companion bill HB 1443 on February 1.

The task force — which is made up of members of the Washington state House and Senate; members of the Black, Latinx, and Indigenous communities; current I-502 licensees; and representatives from several executive agencies including the Department of Commerce — was appointed to make recommendations on how to distribute the state’s reserved $1.1M allocated to assist social equity applicants in attaining retail or producer licenses as dictated by HB 2870.

Following its December meeting, nine I-502 retail owners and producers penned a letter to the Washington State Board of Health urging the entity to open up social equity funding to current license-holders who fit social equity criteria. The letter cites the global pandemic as fiscally challenging for companies with already-tight profit margins, with new CDC protocols and hazard pay to essential workers increasing their daily operating costs. The licensees argued that the task force should first ensure the cannabis market is stable before introducing new license holders, which they argue would best set new equity applicants up for success. Some task force members were opposed, citing that government funds can’t be allocated for one purpose and then used for another based solely on need.

After their meeting in late January, two motions were made — one that shifted the criteria for social equity applicants from being place-based to a prioritization based on race. The prioritization of race follows the motion in December to center Black licensees in their equity efforts. The second motion was to include current I-502 licensees in those eligible to apply for social equity grants.

The Cannabis Observer reported that at one member of the public replied to the latter motion, “How many task [force] members would benefit off this motion?” To which there was no reply.

Rep. Morgan has been working with Sen. Saldaña and her team to craft language in HB 2870 that would widen the scope of their work. With the deadline for recommendations approaching, Morgan said, “House Bill 2870 has really put some barriers around this task force. I feel like we’re trapped inside the current bill that we’re working on, and would love to give us more room to move.”

Along with the focus on serving Black licensee-hopefuls and current I-502 licensees who fit the criteria, the task force’s recommended legislation also calls for the launch of a pilot program by August 2, 2021, to provide technical assistance to retail licensees who meet social equity criteria. The blls would also allocate $150,000 to assist in infrastructure projects, technology upgrades, incubator and mentorship programs, and supplies. Grant recipients would have to show completion of these projects within one year of receiving the grant.

End


South Dakota Planning Cannabis Regulations Despite Court’s Rejection of Legalization Vote

Despite the decision by a South Dakota judge to reject the voter-approved cannabis legalization law, some state lawmakers are still preparing rules and regulations for the industry in case the Supreme Court overturns the lower court decision, the Argus Leader reports, and at least one lawmaker is preparing for the Legislature to consider the reforms.

Republican state Sen. Brock Greenfield told reporters on Tuesday that legalization via the Legislature is “a very real possibility.”

Greenfield has filed a vehicle bill with a generic title stating that the bill pertains to cannabis. Vehicle bills are an empty shell that can be used to carry any cannabis-related legislation not recorded by the Legislative Research Council by the filing deadline, which has already passed for the state’s 2021 session. Theoretically, the entirety of the voter-approved constitutional amendment could be filed into that vehicle bill and formally introduced in the Legislature.

South Dakota Circuit Court Judge Christina Klinger ruled on Monday that the voter-approved law “is a revision as it has far-reaching effects on the basic nature of South Dakota’s governmental system,” and the measure ultimately violated the state’s one-issue clause for ballot initiatives.

State Sen. Arthur Rausch (R), a former judge and attorney, said one of the measure’s downfalls in court – and a major point of opposition for lawmakers – is that it gives rule-making authority solely to the Department of Revenue. He said “there were a lot of bad parts” to the proposal.

“The proponents would be far better off to come to these legislative groups that are working on marijuana and help draft something that works for everybody.” – Rausch to the Argus Leader

The circuit court decision does not impact the medical cannabis law, which was also approved by voters in November. The lawsuit challenging the adult-use legalization law was brought by two law enforcement officers at the behest of Republican Gov. Kristi Noem.

Noem said the court decision “protects and safeguards” the state’s constitution and was confident the Supreme Court would “come to the same conclusion” as the lower court.

End


Kathleen Sebelius, Former Obama HHS Secretary, Joins Cannabis Group’s Board

Kathleen Sebelius, former Health and Human Services secretary for the Obama Administration, has joined the National Cannabis Roundtable as co-chair, Politico reports. Sebelius joins former Republican House Speaker John Boehner atop the organization’s board of directors.

“There is still really a federal framework that makes this growing industry very difficult to operate [in]. That is a considerable concern to me. I think this is a moment of opportunity to really talk about some rational federal policy.” – Sebelius to Politico

Sebelius added that she doesn’t see legalization “necessarily as a Democratic or a Republican issue,” noting that “voters across the country have indicated a willingness and an interest in moving to a new stage with cannabis.”

A Gallup poll from last November found 68% of Americans supported cannabis legalization – the highest level ever recorded by the pollster since it started asking the question in 1969. The poll found support for the reforms by 83% of Democrats, 72% of independents, and 48% of Republicans.

Sebelius is also a former Democratic governor from Kansas – one of just three states that have no legal cannabis. Earlier this month, however, Gov. Kelly Chambers (D) proposed allowing medical cannabis in the state and using funds derived from the industry to pay for Medicaid expansion. Chambers had included medical cannabis reforms in her campaign platform.

Other members of the National Cannabis Roundtable board include Cresco Labs CEO Charles Batchtell, Ilera Healthcare CEO Dr. Chandra Macias, Trulieve CEO Kim Rivers, Mana Supply Co. Co-founder Christopher Jensen, and Liaison Group Principal and CEO Saphira Galoob.

Sebelius is currently the CEO of Sebelius Resources LLC and serves on the boards of directors for Devoted Health, Exact Sciences, Myovant Sciences and other private health sector interests. She also co-leads the Health Strategy Group for the Aspen Institute and works on policy with the Kaiser Family Fund.

End


South Dakota Judge Strikes Down Voter-Approved Legalization Initiative

South Dakota Circuit Judge Christina Klinger ruled on Monday that the state’s constitutional amendment approved by voters in November to legalize adult-use cannabis actually violates a 2018 law that prohibits constitutional amendments from dealing with multiple issues, CBS News reports.

Klinger wrote in her ruling that the amendment “is a revision as it has far-reaching effects on the basic nature of South Dakota’s governmental system,” as it would affect business licensing, taxation, and agriculture with new hemp/cannabis industries.

“Legalization opponents cannot succeed in the court of public opinion or at the ballot box. Thus, they are now seeking to overturn election results in a desperate attempt to maintain cannabis prohibition. Whether or not one supports marijuana legalization, Americans should be outraged at these overtly undemocratic tactics.” — NORML’s Deputy Director Paul Armentano, in a statement

Brendan Johnson, a South Dakota attorney who helped sponsor and defend the legalization amendment, said the group is planning to appeal the decision to the state’s Supreme Court.

The legalization bid, despite passing with 54 percent voter approval on Election Day, was soon challenged by law enforcement officers Highway Patrol Superintendent Col. Rick Miller and Pennington County Sheriff Kevin Thom. According to the report, Miller’s objection was likely made on behalf of Gov. Kristi Noem, who also vocally opposed the legalization efforts.

The amendment was also vocally opposed by Gov. Kristi Noem (R), who appointed Klinger as a circuit judge in 2019. “Today’s decision protects and safeguards our constitution,” she said in a statement. “I’m confident that South Dakota Supreme Court, if asked to weigh in as well, will come to the same conclusion.”

The voter-backed amendment was set to take effect on July 1. That will no longer happen, however, unless Klinger’s decision is overturned by a higher court.

The latest Gallup poll found that 68 percent of Americans — more than ever — support ending the prohibition of cannabis.

End


New Mexico May Revoke License of Company Behind Extraction Fire

New Mexico regulators are considering revoking the license of the company that operated the facility where two workers were seriously injured in a fire last October, the Associated Press reports. The accident at New Mexicann Natural Medicine occurred during the extraction process when a mixture of ethanol and cannabis oil spilled onto a heater plate.

It was the second fire, described prior to the investigation as an explosion, at the facility that caused injuries over five years.

Officials contend that New Mexicann didn’t train staff on how to properly use the equipment. The Health Department immediately suspended the company’s manufacturing license following the incident. According to the December 21 notice outlined by the Santa Fe New Mexican, the producer violated medical cannabis program regulations by not using a closed-loop system to make concentrates and by instructing employees to stir the contents of the open container during the extraction process without directing them to turn off or cool the heater plate first.

“By lifting an open extraction vessel containing an ethanol-based solution in the immediate vicinity of an active heater plate, New Mexicann engaged in conduct that showed a willful and reckless disregard for health and safety.” – Medical Cannabis Program Director Dominick Zurlo, in the notice, via the New Mexican

A previous fire at the plant in 2015 severely burned two employees involved in the extraction process. Following that incident, Occupational Safety and Health Administration cited the company for 12 “serious” health and safety violations and fined it $13,500. The state Occupational Safety and Health Bureau cited the company for seven serious violations and levied a $7,250 fine for that accident, according to NM Political Report.

A hearing for the matter was reportedly scheduled for January 4 but was rescheduled.

New Mexicann has been licensed in the state since 2009.

End


Cannabis Entrepreneur Elected to Pro Football Hall of Fame

Calvin Johnson, the former Detroit Lions star wide receiver and founder of Michigan-based cannabis company Primitiv, has been elected to the Pro Football Hall of Fame. Johnson, better known to fans as “Megatron,” played nine seasons in the National Football League and in an interview last year indicated he used cannabis throughout his career to help with the concussions he suffered during his playing days.

“When I got to the league, [there] was opioid abuse. You really could go in the training room and get what you wanted. I can get Vicodin, I can get Oxy[contin]. It was too available. I used Percocet and stuff like that. And I did not like the way that made me feel. I had my preferred choice of medicine. Cannabis.” – Johnson to Bleacher Report

Following his football career, Johnson, along with former teammate Rob Sims, founded Primitiv, which in 2019 announced a partnership with Harvard University to research the effects of cannabis on chronic traumatic encephalopathy (CTE) and pain management. A 2017 study published in the Journal of the American Medical Association found 110 of 111 brains of former NFL players were found to have the degenerative disease linked to blows to the head.

Neither Johnson nor Sims have been diagnosed with the condition.

In 2019, Johnson and his wife, Brittney, were approved for pre-qualification status for a medical cannabis dispensary, according to a Detroit Free Press report. The planned dispensary, Michigan Community Collective, is not a Primitiv project.

Last year, the Primitiv founders signaled plans to open a dispensary, called Prime, in Niles. The duo said they may even consider doing autograph signings and other events at the shop due to their NFL connections, the South Bend Tribune reported.

Johnson, who spent his entire career with the Lions and set the single-season receiving record in 2012 with 1,964 yards, was voted into the Hall of Fame on his first ballot appearance.

End


MSOs, Tech Firms, MPP, and Others Launch U.S. Cannabis Council

A new national cannabis advocacy organization, the U.S. Cannabis Council, announced its formation on Monday saying it “aims to advance social equity and racial justice, and end federal cannabis prohibition.” The organization, a 501(c)4 nonprofit, counts cannabusinesses, associations, and advocacy organizations among its founding members.

USCC Interim CEO Steven Hawkins, who also serves as executive director of the Marijuana Policy Project, described the organization as “a unified voice advocating for the descheduling and legalization of cannabis.”

“Legalization at both the state and federal level must include provisions ensuring social equity and redress for harms caused to communities impacted by cannabis prohibition.” – Hawkins, in a press release

Founding members of the organization include:

  • Acreage Holdings
  • Akerna Corp.
  • American Trade Association of Cannabis and Hemp
  • Association for Cannabis Health Equity and Medicine
  • BellRock Brands
  • Buckeye Relief
  • Cannabis Trade Federation
  • Canopy Growth Corporation
  • Columbia Care Inc.
  • Cresco Labs Inc.
  • Cronos Group
  • Culta
  • Curaleaf
  • DNA Genetics
  • Eaze
  • Flowhub
  • Global Alliance for Cannabis Commerce
  • Good Chemistry
  • The Grove Cannabis Dispensary
  • Headcount’s Cannabis Voter Project
  • Husch Blackwell
  • iAnthus Capital Holdings, Inc.
  • Jushi
  • Keef Brands
  • Lightshade
  • LivWell Enlightened Health
  • Marijuana Policy Project
  • Medicine Man
  • MedMen
  • Native Roots Cannabis Co.
  • 1906 New Highs
  • PAX Labs
  • PharmaCann
  • ProKure
  • Raw Garden
  • Schwazze
  • Scotts Miracle-Gro Company
  • Urbn Leaf
  • Veterans Cannabis Project
  • Vicente Sederberg LLP
  • Vireo
  • Wana

The organization has already received support from Oregon Rep. Earl Blumenauer (D), one of the staunchest supporters of federal cannabis law reforms and founder and co-chair of the Congressional Cannabis Caucus.

“We have a unique opportunity in the 117th Congress to advance cannabis reform, but we must remain united to create the change we know is possible,” Blumenauer said in a statement. “I look forward to welcoming the United States Cannabis Council to Washington, D.C. and working together toward meaningful policy change in the months and years ahead.”

Other members of the USCC includes Heather Azzi, general counsel for the Cannabis Trade Federation who will serve in that role for the USCC; Executive Assistant Brianca Hurley, who serves in the same capacity for the MPP; Deputy Vice President for Government Relations Chris Lindsay, who serves as a legislative analyst for the MPP; and Global Alliance for Cannabis Commerce Executive Director Randal Meyer as vice president of government relations.

End


Minnesota Bill Would Reschedule Cannabis to Let Patients Access Firearms

Minnesota Republican state Rep. Rod Hamilton is proposing a bill to reclassify medical cannabis in the state as a Schedule 2 drug in an effort to allow patients to legally keep their firearms under federal law, KSTP 5 reports.

Under federal law, medical cannabis patients lose their rights to own and possess firearms as cannabis remains a Schedule I drug under the Controlled Substances Act. Federal background check forms for firearms include a question about cannabis use and officials are able to search state databases to determine whether someone seeking to buy a firearm is also a registered patient in a medical cannabis program.

Hamilton, who has multiple sclerosis and is registered with the state’s medical cannabis program, said he has been unable to renew his permit to carry a gun or legally use a firearm to hunt due to federal law.

“We need to do this, along with other states like Oklahoma, to get the attention of Congress in Washington, D.C. It needs to change at the federal level and here so people can legally get their gun permits renewed and so they can hunt with family and friends and not be in violation of the law.  No one in the medical cannabis program wants to be in violation of the law.” – Hamilton to KSTP

According to the report, there are some 43,000 registered patients in Minnesota.

During his push last year to implement the reforms, which were stalled due to the coronavirus pandemic, Hamilton shared a letter from the U.S. Department of Justice Bureau of Alcohol, Tobacco, Firearms and Explosives that said, “there are no exceptions in Federal law for marijuana purportedly used for medicinal purposes, even if such use is sanctioned by State law.”

Hamilton has not yet introduced a bill for this session; however, last year’s measure included six Republican co-sponsors.

End


New Jersey Lowers Penalties for Psilocybin Possession

New Jersey Gov. Phil Murphy (D) signed a bill last week loosening penalties for the possession of psilocybin mushrooms, according to NJ.com.

The legislation lowers the possession of up to one ounce of psilocybin from a third-degree crime to a disorderly person offense but does not completely decriminalize mushrooms. However, instead of facing three to five years imprisonment, the longest jail sentence someone might serve for the substance would be six months and up to $1,000 in fines.

The idea to decriminalize psilocybin mushrooms was first proposed during cannabis reform negotiations after New Jersey voters approved the legalization of adult-use cannabis in November. Originally coupled with the cannabis legislation, the mushroom bill stalled negotiations, however, resulting in lawmakers splitting the issues into two bills and approving them separately from one another.

The psilocybin bill was the first drug reform bill signed this session by the governor, who has cited concerns around youth possession rules as a reason for not immediately approving the legislature’s cannabis legalization language.

Denver, Colorado was the first U.S. city to decriminalize psilocybin in 2019. Since then, other cities have taken up the issue, including Washington D.C. and, most recently, the state of Oregon passed a bill legalizing the medicinal use of psilocybin mushrooms. The ongoing movement is driven by broadening awareness of the medicinal uses of psilocybin in treating conditions like PTSD and new efforts to decriminalize entheogenic plants used by indigenous people, and others, for religious or spiritual purposes.

End


Australian Cannabis Company Loses $3.6M in Fraud Scheme

Australian cannabis company Cann Group Limited said it had lost $3.6 million in a “cyber security incident” involving payments meant for an overseas contractor related to work at its Mildura, Victoria facility.

The company, which trades on the ASX, said it discovered the breach on February 4 and it is “currently under investigation.” Cann said the payments to the contractor had been “received by an unknown third party as a result of a complex and sophisticated cyber fraud perpetrated against the company and its overseas contractor.” The contractor was unnamed in the Monday announcement.

“The Company is working with its bank to determine if any of the payments can be halted and if any of the funds involved are recoverable. The Company has notified its insurance brokers to determine if a claim can be made to recover any of the losses involved. Immediate action has also been taken to ensure the integrity of Cann’s IT systems.” – Cann Group Limited, Feb. 8, 2021, ASX Announcement

The firm said it remains in a “financial position to continue with its ongoing operations and projects,” including the Mildura facility, “irrespective of any funds being recovered.”

The company said it has alerted authorities in Australia, the Netherlands, and Hong Kong.

Last Christmas, Canadian cannabis company Aurora was the victim of a hack into its Microsoft Cloud software which led to company and employee data ending up for sale online.

Last year, cannabis point-of-sale system THSuite was targeted by hackers who ended up leaking 85,000 files from dispensaries throughout the U.S., including more than 30,000 records containing personally identifiable information.

Note: All figures in Australian dollars

End


Wisconsin Gov. Includes Adult-Use Legalization in Executive Budget Proposal

Wisconsin Gov. Tony Evers (D) is including cannabis legalization in his 2021-2022 budget proposal, MyStateline.com reports. The plan includes possession limits for residents up to two ounces and allows cultivation up to six plants but would allow non-residents to possess only a quarter ounce.

“Legalizing and taxing marijuana in Wisconsin – just like we do already with alcohol – ensures a controlled market and safe product are available for both recreational and medicinal users and can open the door for countless opportunities for us to reinvest in our communities and create a more equitable state. Frankly, red and blue states across the country have moved forward with legalization and there is no reason Wisconsin should be left behind when we know it’s supported by a majority of Wisconsinites.” – Evers, in a statement, via MyStateline

The Governor’s Office estimates that legal cannabis would generate more than $165 million annually starting in fiscal year 2023. The plan would earmark $80 million of cannabis-derived revenues for a new community reinvestment fund, including $30 million in social equity grants through the Department of Health Services, the Department of Administration, and the Department of Children and Families, $5 million in grants to underserved communities through the Wisconsin Economic Development Corporation, and more than $34 million for rural school districts, the Governor’s Office said. The remaining funds would be deposited into the state’s general fund.

Evers joins New York Gov. Andrew Cuomo, also a Democrat, in including adult-use reforms in the executive budget proposal. Democratic governors Ned Lamont in Connecticut and Lujan Grisham in New Mexico have also called for the reforms as lawmakers begin their 2021 legislative sessions.

In Wisconsin, both chambers of the legislature are controlled by Republicans. The leaders of both chambers, Devin LeMahieu in the Senate and Jim Steineke in the House, each received “F” grades from NORML due to their opposition to cannabis law reforms.

End


Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

Former National Football League running back Marshawn Lynch on Thursday launched Dodi Blunts, a “premium, crafted cannabis brand-platform” that includes THCa “diamonds,” Mercury News reports.

The endeavor is a partnership between Lynch and Toronto, Canada-based 2nd and Goal Ventures.

Lynch, a four-time All-Pro and one-time Super Bowl champion with the Seattle Seahawks nicknamed “Beast Mode,” said “Fans who indulge in the first run of Dodi Blunts will experience the highest, richest potency from palm leaf-wrapped blunts infused with THCa diamonds presented in a reusable blunt tube.”

“And at the end of the day, the industry has the ability to raise up Black and Brown communities – and I intend to lift up those who I can. Plus, Dodi allows me to share with the world. What gets me (and my fam) in our zone, so others can get on my level.” – Lynch, in a statement, via 8 News Now

Prior to the Raiders moving from Oakland to Las Vegas, Lynch was caught off-camera lighting a blunt with the Al Davis Memorial Torch. Lynch said, “it was only right to send the Raiders off in a real Oakland way.” He retired before the team’s move to Vegas.

Jeff Goldenberg, 2nd and Goal founding partner, told 8 News Now that Dodi Blunts “challenges the traditional concept of ‘Game Day’ rituals and hopes to promote and normalize the relationship between sports and cannabis cultures.”

“Dodi Blunts is launching with the first athlete of Marshawn’s caliber at a moment in time when all the canna-stars are aligning: sports, culture and society, and politics and legalization,” he said in a statement.

Other former NFL players that have entered the cannabis space include Ricky Williams, Tiki Barber, Eugene Monroe, Joe Montana, and Marvin Washington.

Last year, the NFL announced it would no longer suspend players for positive cannabis results. Prior to the change, the league had the strictest cannabis policy among the four major U.S. sports leagues.

Following the announcement of Dodi Blunts, multiple mainstream media outlets including a Fox News subsidiary botched their reporting of the product launch, incorrectly suggesting that the “diamond-infused” blunts contained literal 24-carat diamonds.

End


Canada’s Regulated Cannabis Sales Finally Overtake Legacy Market

Licensed adult-use cannabis sales in Canada exceeded unlicensed sales for the first time during the third quarter of 2020  – by about $70 million, according to figures from Statistics Canada. Legal sales during the quarter reached $824 million while estimated illegal sales were $754 million.

Medical cannabis sales in the country were $146 million during the quarter, the lowest in the five quarters outlined in the government data.

Adult-use sales in the third quarter of 2020 far outpaced sales in the previous four quarters, overtaking quarter two sales by $194 million and doubling the $408 million realized in the third quarter of 2019, according to Statistics Canada data.

Unlicensed cannabis sales in Canada have been dropping steadily since the third quarter of 2019 when they were estimated at $935 million. In the following quarters, illegal sales fell to $890 million (Q4 2019), $842 million (Q1 2020), and to $801 million (Q2 2020).

In December, Ontario Auditor General Bonnie Lysyk released a report that found unregulated transactions comprised about 80% of the province’s sales, saying that products outside of the licensed market were of better quality than their regulated counterparts.

Industry activists and law enforcement agencies have contended that the lack of oversight on personal cultivation allowed under the nation’s medical cannabis laws also drove unregulated market products. About 34,000 Canadians have a license to grow cannabis for personal use.

George Smitherman, CEO of the Cannabis Council of Canada, told MJBizDaily that the quarter three figures illustrate “the success of one of the policy goals, which is bringing sales into the legal framework.” He added the “price decreases on key verticals of dry flower have been essential for transitioning many of those consumers.”

Note: All figures in Canadian dollars

End


Idaho Senate Passes Bill to Ban Cannabis Legalization Efforts

The measure to constitutionally ban any legalization of non-pharmaceutical psychoactive drugs in Idaho passed the Senate by a single vote on Wednesday, Boise State Public Radio reports. The proposal would still have to pass the House by two-thirds before moving to voters via a ballot initiative next year.

Republican State Sen. Scott Grown, the bill sponsor, has oft referred to the state as the “last foxhole” in the region without any form of legalized cannabis. Idaho is bordered by Washington state, Oregon, Nevada, and Montana – which have legalized cannabis for adult-use – and Wyoming and Utah, which have both legalized cannabis for medical use, although Utah’s program is extremely limited after lawmakers replaced a voter-approved initiative with a program of their own.

Earlier this month, House lawmakers from both sides of the aisle announced a plan to legalize medical cannabis in the state as activists are simultaneously running a ballot initiative campaign to get the reforms on ballots next year.

Hemp also remains Illegal in Idaho as lawmakers blocked a bill to legalize the industrial crop last year. Although, Gov. Brad Little (R) signed an executive order to explicitly allow hemp to be transported through the state after police arrested several truck drivers for hauling hemp.

If the constitutional amendment is approved by voters, the cannabis restriction would also apply to the state’s “right to try” law which allows terminally ill patients to be prescribed experimental drugs.

Some GOP members opposed the bill citing concerns that it would complicate the state’s constitution.

End


Alabama Senate Committee Advances Bill to Legalize Medical Cannabis

The Alabama Senate Judiciary Committee has passed a medical cannabis bill, picking up where they left off last year before the COVID-19 shut down, according to AL.com.

SB 46, known as the Compassionate Care Act, is essentially the same bill that passed the Senate last year and is sponsored by state Sen. Tim Melson (R), who has introduced medical cannabis bills for the last three years in Alabama. The bill would allow Alabamians with a select group of medical conditions to “register” for a medical cannabis card. The Act would set up an 11-member “Medical Cannabis Commission” that would oversee everything from seed to sale tracking, to registering patients and dispensing cannabis.

“It’s encouraging to see lawmakers making progress towards legalizing medical marijuana in Alabama,” Karen O’Keefe, state policies director for the Marijuana Policy Project, told Marijuana Moment. “It is morally wrong to continue to treat Alabamians who suffer from serious medical conditions as criminals for using a substance that is now legal in 36 states.”

Some of the provisions of the bill include sending 60 percent of the funds from a nine percent medical cannabis tax to the General Fund and 30 percent to studying the medical effectiveness of cannabis. Doctors would be required to take a four-hour continuing erducation course in order to recommend medical cannabis. Medical cannabis products would be limited to a narrow list, including capsules, lozenges, oils, suppositories, and topicals, eliminating all forms of edible and smokable/vapeable cannabis.

O’Keefe commented on the product restrictions: “We urge lawmakers to revise the provisions of the bill that create significant barriers for patients and their physicians.”

End


Fox News Subsidiary Botches Coverage of Marshawn Lynch Cannabis Brand

Former NFL running back Marshawn Lynch is not launching a cannabis product line infused with actual 24-carat diamonds, as was reported by several media outlets this week including Q13 FOX Seattle. Rather, Lynch’s Dodi Blunts product line will feature blunts infused with THCa crystals, a highly potent concentrate commonly called “diamonds” because of their rocky, crystalline appearance.

The media outlets in question appeared to center their reporting on the products’ “diamond-infused” description without looking further into what the term means in the context of the cannabis industry.

One article, attributed to “Q13 News Staff,” incorrectly asserted that Dodi Blunts will contain 24-carat diamonds and also tread a fine line between attempted humor and racial pandering, stating that Lynch, who is Black, is “bringing the bling to blunts.”

THCa diamonds are crystalline structures that form at the bottom of a THCa sauce extract. They are an incredibly potent form of cannabis concentrate.

“Our diamonds champion the highest, richest potency to uplift you to your peak. Gorgeous yet beastly, these THCa diamonds pack each blunt with super THC power.” — Product description excerpt, via Dodi Blunts

Dodi Blunts is the result of a recent partnership between the former NFL pro and Toronto, Canada-based 2nd and Goal Ventures. The products will be available at a selection of handpicked cannabis dispensaries throughout the San Francisco Bay Area.

End


Oregon Proposes Cannabis Social Equity Program

The Cannabis Equity PAC — a coalition of Oregon cannabis businesses, activists, and politicians — has announced the introduction of the Oregon Cannabis Social Equity Act, the group said in a press release.

HB 3112 would use cannabis tax dollars to help repair the damage done by the “War on Drugs.” Led by former state Rep. Akasha Lawrence-Spence, the group includes the NuLeaf Project, the Oregon Cannabis Association, the Oregon Retailers of Cannabis Association, the City of Portland, Urban League, and law students from Willamette University.

“We came together with a common purpose — to undo and repair some of the harm caused by cannabis criminalization on Black, Indigenous and Latinx communities in Oregon.This legislation uses cannabis tax revenue to invest in Oregonians who have been unjustly targeted for decades by law enforcement, in an effort to repair some of the generational harm done to their communities.” — Former Rep. Spence, in a statement

The bill has bi-cameral sponsorship and has three major provisions: direct investment into housing, job training and health care for Black, Indigenous, LatinX, and others convicted of cannabis crimes; the free and automatic expungement of eligible cannabis crimes; and social equity licenses that will have lower application fees, initial requirements. The bill also expands three license types to be more beneficial to small business owners.

“We’ve seen the harm to far too many families to not address this issue,” said Jeanette Ward Horton, the Executive Director of the New Leaf Project. “Cannabis convictions bring challenges that ripple through families and cause hardship for the children of children whose parents were disproportionately arrested. The loss of jobs, education grants, housing and more that can all stem from a minor cannabis conviction have impacted communities of color for generations. Today Oregon has the chance to undo some of that harm.”

Oregon already has a formal process to expunge cannabis crimes. However, according to Rep. Ricki Ruiz, a chief sponsor for the bill, “Less than 200 out of 28,000 Oregonians eligible for expungement were able to successfully complete the process in the past two years. We need to do better.”

“This bill provides us the path and the funding we need to efficiently remove previous cannabis crimes from people’s records and provide them the opportunity to repair their lives from the harm caused by cannabis criminalization,” he said. “It is a critical step toward restoring the health of these individuals and the communities where they reside.”

End


Report: Montana Has Highest Racial Disparity In Cannabis Arrests

In Montana, Black people are 9.6 times more likely to be arrested for cannabis possession than their white counterparts – the widest disparity in the U.S., according to American Civil Liberties Union data compiled by the Cincinnati, Ohio-based Joslyn Law Firm. Colorado had the lowest racial disparity with Black people 1.5 times more likely to be arrested for possession.

The report uses data from 2010 to 2018.

The largest racial disparities in cannabis possession arrests were in Pickens County, Georgia, where the arrest rate of Black people was 97.3 times higher than the white arrest rate – 321 white people were arrested for marijuana possession during the period analyzed compared to 31,243 Black people. DeKalb County, Alabama was the second-highest county for racial disparities in cannabis arrests at 44.6 to 1, the report found.

Nationally, Black people are 3.6 times more likely to be arrested for cannabis possession than their white counterparts – this despite studies that have found Black and white people use cannabis at similar rates.

In Kentucky, Black people were arrested for possession 9.4 times more often than white people, followed by Illinois, Iowa, and West Virginia at 7.5 times and 7.3 times each, respectively. The report does not include post-legalization data from Illinois, which was the first state to legalize cannabis via the Legislature in 2019. Illinois State Police and the governor expunged more than 500,000 cannabis-related criminal records on the final day of 2020.

Minnesota, North Dakota, South Dakota, and Wyoming all saw Black people arrested for cannabis possession at rates at least five times higher than white people, while Utah neared the mark at 4.9 times, the report found. Alabama, Connecticut, Delaware, New Hampshire, Maine Massachusetts, New Mexico, Kansas, Oklahoma, and Wisconsin all saw cannabis arrest rates four-times higher among Black people and of those states only Massachusetts has legalized sales and possession for adults. Idaho was close to the mark with cannabis arrest rates 3.9 times higher for Black people than white people int the state.

Michigan arrest rates were consistent with the national average of disparities, followed by Arizona, Georgia, Indiana, Louisiana, Ohio, Pennsylvania, Nebraska, Nevada New Jersey, Rhode Island, North Carolina, South Carolina, Tennessee, which reached a three-times rate of disparity but fell below the 3.6% average.

Arkansas, Maryland, Mississippi, Missouri, New York, Texas, and Washington state each saw arrest rate disparities between 2.1 and 2.9 times, while Alaska, California, Colorado, Hawaii, and Oregon saw disparate rates between 1.5 and 1.8 times. Three of those four states have legalized cannabis for adults.

End


Minnesota Democrats Ramp Up Cannabis Legalization Messaging

Minnesota Democrats are making the case for legalizing adult-use cannabis and expunging low-level cannabis crimes in the state, the Associated Press reports.

“The issue of legalizing cannabis, creating a fair, regulated marketplace, addressing the deep inequities in our criminal justice system, is a mainstream, bipartisan, broadly supported issue,” Democratic House Majority Leader Ryan Winkler said in a news conference earlier this week.

Joining other Mid-West states like South Dakota, Michigan, and Illinois, Minnesota would become the 16th state to embrace adult-use cannabis — but Democrats continue to face opposition from Republicans.

Republican Senate Majority Leader Paul Gazelka summed up GOP concerns: “We are focused on the Minnesota Priorities that balance the budget without raising taxes, safely reopen schools and businesses to recover our economy, and support families. I would not consider legalizing recreational marijuana as a Minnesota priority.”

Democratic Gov. Tim Winkler, who introduced an adult use cannabis bill last year ahead of the COVID-19 crisis, supports the push and has traveled around the state building momentum for adult-use cannabis for the past year and a half, the AP reports.

Other Democrats, like Rep. Rena Moran, say legalizing adult-use cannabis is key to breaking down systemic racism in Minnesota.

“Nowhere is the harm of the failed criminal prohibition felt more than for Black, Indigenous and people of color, which continue to experience outrageous disparities regarding enforcement of our current marijuana laws. Black Minnesotans are over five times more likely to be arrested for marijuana than those who are white. This is one of the worst disparities in the nation, and true even though both groups use it at similar rates.” — Rep. Moran, in a statement

End


Springbig Acquires BudTender Giving it Access to Canadian Retailers

Florida-based cannabis loyalty marketing and communications technology company springbig on Tuesday acquired Canada-based customer experience platform BudTender, creating what the company called “the most in-depth marketing, loyalty, and retention platform for cannabis dispensaries and brands.”

The terms of the deal were not disclosed.

Through the acquisition, BudTender will add over 200 clients to springbig’s existing customer base, increasing springbig’s market share to over 1,900 retailers throughout the U.S. and Canada.

Jeffrey Harris, springbig’s founder and CEO, said BudTender’s “vision and platform effortlessly complements springbig’s ongoing commitment to enhancing the cannabis retail and loyalty experience.”

“As the legal industry becomes increasingly sophisticated, brands and retailers will need to deploy more comprehensive customer retention and satisfaction solutions in order to stay competitive.” — Harris in a statement

Budtender CEO Jake Crow said the acquisition will “be a boon to cannabis retailers across North America” while enriching customer experiences and “will undoubtedly create a more modern cannabis industry.”

BudTender will integrate into springbig’s platform, allowing retailers and brands to access customizable customer surveys, weekly reports, an AI-powered feedback platform, 24/7 customer support, and track key performance indicators in real-time.

Last year, BudTender experienced 800% year-over-year store growth and 1,200% year-over-year revenue growth, the company said in a press release. Springbig, which was founded in 2017, develops custom cannabis industry loyalty software and boasts a 99% open rate on its targeted and personalized text message campaigns.

BudTender was already being used by more than 200 retailers in the U.S. and Canada.

End


Is Cannabis Good for Pain Relief?

Jointly is a cannabis wellness app that launched in April 2020. Jointly’s mission is to help people discover purposeful cannabis consumption. Purposeful cannabis consumption starts with the question: why do you use cannabis?

Many people use cannabis or CBD to manage their chronic pain. What does it look like to use cannabis or CBD to manage pain?

It could be a young woman who finds that a few puffs from a high THC vape pen at the onset of her migraines dramatically decreases her symptoms; or a hard-charging dad who uses CBD capsules to soothe his inflamed joints after a weekend of hiking with his grown children; or a cancer survivor with lingering nerve pain from chemotherapy who traded prescription opiates for a few puffs from a joint on the recommendation of her doctor.

Is Cannabis Good for Pain Relief?

Cannabis has been used to soothe pain for at least 5000 years. While cannabis may not be a mainstream pain reliever anymore, the majority of medical marijuana patients use cannabis to manage their chronic pain. Many feel it is highly effective.

For example, a 2019 survey of medical cannabis patients found that 65% of patients reported taking cannabis to relieve pain, and of that group, 80% reported that cannabis was “very or extremely helpful” for managing their pain.

A separate study conducted on 2987 people reporting their cannabis use and symptom relief found that cannabis benefitted numerous pain conditions including non-specified pain, headaches, back, muscle or joint pain, and gastrointestinal pain. These researchers noted that whole cannabis flower was associated with greater pain relief than any other type of product, and that higher THC levels were “the strongest predictors of analgesia.” Interestingly, CBD levels “were not associated with pain relief.”

Clearly, people feel that cannabis helps them manage their pain, but these data come from self-reported studies rather than clinical studies. What do clinical studies indicate about cannabis and pain?

What Does the Science Say About Cannabis and Pain?

The scientific literature holds seemingly contradictory findings. For example, despite the survey results above, many clinical studies indicate that cannabinoids have only weak analgesic properties.

A 2018 editorial published in the Journal of Applied Laboratory Medicine (JALM) states, “systematic reviews in acute pain are unequivocal in pointing out the lack of effectiveness of cannabinoids,” and “the reviews in chronic pain, mostly neuropathic, have arrived at similar conclusions, that cannabinoids and medical cannabis provide small analgesic benefit.”

How is it possible that people feel cannabis is highly effective at managing their pain, but clinical trials indicate that cannabinoids and cannabis are weak or ineffective analgesics?

Limitations of Cannabis Research

Decades of prohibition have created a situation where there simply aren’t many scientifically rigorous studies on cannabis and pain. As a result, “the current clinical debate continues to be driven, in large part, by variable analyses and perspectives of the same extant clinical trials.”

However, prohibition is only a piece of the puzzle. Many of the studies that found minimal benefit for pain used synthetic cannabinoids. Modern medicine and pharmacology follow a standard path of developing “safer and more efficacious drugs than plants themselves.”

However, there is evidence that isolated cannabinoids and synthetic cannabinoids may have less therapeutic benefit than the whole plant. For example, a 2018 review published in Pharmacotherapy states, “surprisingly, and as an unforeseen paradox to modern pharmacy…oral pharmaceutical grade cannabinoids show conflicting results in patients with chronic pain.” The authors of the review note that the evidence indicates that “oral cannabinoids are inferior when compared to…the cannabis plant.”

The editorial in JALM concedes, “it may be presumptuous to conclude that the major clinical effects of cannabis are derived solely from THC and cannabidiol (CBD). What becomes lost in the rhetoric…[is] the putative analgesic effects of terpenes and flavonoids.”

Beyond terpenes and flavonoids, there may be lesser-known cannabinoids in the whole cannabis plant that contribute to its pain-relieving effects. For example, a September 2020 article published in the medical journal Comprehensive Clinical Medicine notes that there are “hundreds of cannabinoid compounds…in the cannabis plant that variably activate CB1 and CB2 receptors.”

Part of the reason why clinical studies produce mixed results seems to be that these studies use isolated or synthetic cannabinoids, which seem to have less therapeutic benefit than the whole plant. In line with this idea, many surveys and self-reported studies indicate that cannabis flower is more effective than other types of products for relieving pain.

Supporting this notion, the National Academy of Sciences, Engineering, and Medicine found “substantial evidence that inhaled cannabis is effective for the treatment of chronic pain in adults.”

What Type of Pain Does Cannabis Help With?

There are three main pain systems: nociceptive pain, neuropathic pain, and central pain.

When your tissue is inflamed or injured, special pain detecting neurons called nociceptors transmit this information “via nociceptive pathways in the spinal cord to the brain.” Your brain interprets these signals and creates the subjective experience of pain.

In nociceptive pain, the nervous system is functioning normally and noxious stimuli like disease, inflammation or injury activate the nociceptors, “leading to organized responses that defend the tissue under threat and aid in its repair.”

Neuropathic pain is caused by “damage to sensory or spinal nerves, which send inaccurate pain messages to higher centers.” Neuropathic pain is characterized by spontaneous pain, allodynia (pain from normally innocuous stimuli), and hyperalgesia (excessive pain from something that would normally be mildly painful).

Central pain can be nociceptive or neuropathic, but it is caused by “dysfunction that specifically affects the central nervous system, which includes the brain, brainstem and spinal cord.” Fibromyalgia is the classic example of central pain. Basically, the central nervous system amplifies the pain signal, making the pain impossible to ignore.

Pain researchers discovered that in some circumstances, acute pain can lead to “hyperexcitability” of the nociceptors, essentially lowering the threshold needed to activate these pain neurons. This plasticity is unique: “unlike other sensory systems, nociceptive systems can sometimes undergo very long lasting, even permanent, enhancement of function following sufficiently intense activation.”

This process leads to “amplification of incoming [pain] signals,” and is a substantial part of neuropathic and chronic pain conditions. These chronic pain conditions are difficult to treat, but there is evidence that cannabis is effective for managing these types of pain.

A 2019 review of cannabis and pain found that oromucosal sprays are effective in reducing chronic and neuropathic pain caused by cancer, that inhaled cannabis flower is effective in reducing neuropathic pain in general, and that oral cannabis is effective for nociceptive pain.

Your Brain Creates Pain

During World War II, H.K. Beecher, a physician serving with the U.S. Army, observed that nearly three-quarters of severely wounded soldiers were “alert, responsive and not in shock…reported no to moderate pain [and] did not want pain relief medication.” Beecher’s observations were the first indication that the body has natural mechanisms of modulating pain, which we now know can either diminish or magnify pain.

Pain modulation refers to the process by which “the body alters a pain signal as it is transmitted along the pain pathway.” This innate pain modulation is an important part of how cannabis helps people manage pain. While endorphins (the body’s endogenous opioids) are known to play a role in pain modulation, preclinical studies have revealed that the endocannabinoid system plays an important role as well.

For example, when researchers injected rats with naloxone, an opioid receptor antagonist that blocks the effects of opioids, alongside a synthetic cannabinoid that exerts similar effects to THC, they observed effects “analogous to the effect of morphine, but these effects were not blocked by naloxone, indicating that these effects are mediated specifically through cannabinoid receptors.”

How Does the Endocannabinoid System Modulate Pain?

After an injury, the body produces endocannabinoids that reduce inflammation and pain signaling at the site of injury, which reduces pain.

As Kevin Hill, MD et al. write in their 2017 clinical review of cannabis and pain, “understanding the function of endogenous cannabinoids helps explain the efficacy of exogenous cannabinoids…in treating pain.”

The endocannabinoid system is made up of the CB1 (cannabinoid receptor 1) and CB2 receptors and the endogenous cannabinoids (anandamide and 2-AG) that bind to them. The CB1 receptors are found in the brain, nervous system, peripheral organs and tissue, while the CB2 receptors are found primarily on immune cells, although they are also found on bone, spleen and liver cells.

Research has shown that the endocannabinoid system “acts independently of the opioid pathway to control pain signaling, immune activation, and inflammation.” Scientists have found that CB1 receptors are “found in high concentrations in areas of the brain that modulate nociceptive processing, with a similar distribution to opioid receptors.”

There is evidence that both CB1 and CB2 receptors play a role in cannabinoid pain relief, but the CB1 receptor is thought to have the most direct influence on pain processing pathways.

How Does Cannabis Relieve Pain?

Both cannabinoids and opioids relieve pain through a mechanism that “blocks the release of pain-propagating neurotransmitters in the brain and spinal cord.” Activating the cannabinoid receptors “by endogenous or extraneously administered cannabinoids” inhibits pain signals and neurotransmitter release locally, at the spinal level and at the supraspinal level.

As Kevin Hill, MD et al. write in their clinical review, due to the complex ways that the endocannabinoid system modulates pain, “the biologically hypothesized rationale for cannabinoid administration is whole-body exposure to exogenous cannabinoids to turn on pain inhibition.”

There is also evidence that when the endocannabinoid system is activated, it downregulates neuronal hyperexcitability. If you recall, this hyperexcitability of neurons is a primary factor involved in the development and maintenance of chronic pain and neuropathy.

How Does CBD Relieve Pain?

There are a variety of mechanisms by which CBD can help people manage pain. While CBD doesn’t bind to cannabinoid receptors, it does increase the levels of anandamide, the endocannabinoid that binds to CB1 receptors (like THC). As established, the CB1 receptors play an important role in pain modulation.

However, the effects of CBD on chronic pain “are likely due to modulation of multiple non-endocannabinoid signaling systems.”

For example, CBD “enhances the activity of [GABA] receptors,” which can dampen pain signals as they enter your brain. CBD is also “a potent antioxidant.”

Additionally, “the pharmacodynamic profile of CBD resembles those of many currently prescribed treatments for neuropathic pain,” and research has demonstrated that CBD has a marked anti-inflammatory effect in animals and in in vitro experiments. At present, the research into how CBD affects inflammation in humans is “limited and inconclusive.”

Cannabis Makes Pain More Tolerable?

Many factors can affect how pain is experienced: your emotional state, your degree of anxiety, whether you are distracted or focused on the pain, your expectations about the pain, etc.

Experimental studies on cannabis and pain indicate that cannabis increases the threshold at which participants feel pain, and decreases the unpleasantness of pain, but does not reduce the intensity of pain.

A separate study drew the conclusion that cannabis affected only one of three subjective measures of pain: bothersomeness. The other two measures were pain intensity and a McGill Pain Questionnaire.

These findings are important in understanding why cannabis is such an effective tool for managing pain. While cannabis may not decrease the intensity of pain in the same way opioids do, it makes pain more tolerable — and also does not seem to increase sensitivity to pain in the way opioids do.

Cannabis has the ability to affect “the emotional component of pain” by boosting mood, reducing symptoms of anxiety or depression, and “offering some degree of dissociation from physical symptoms.”

According to the biopsychosocial model, pain is not simply a biological process, but one that involves a person’s psychology and larger social network. If pain is less bothersome, it may be psychologically easier to tolerate and have less of a negative impact on well-being. Please note this information is for educational purposes only, and any changes to your pain management strategy should be discussed with your doctor.

Curious if cannabis or CBD can help you manage pain?

Use Jointly to Manage Pain with Cannabis and CBD

With Jointly, you measure how well a cannabis product helps you achieve your wellness goals, including pain management.

As you record how well a product helps you manage your pain, Jointly helps you track the 15 factors that can impact your results so that you can enjoy your ideal experience every time and minimize any side effects.

Jointly users who have optimized their cannabis consumption by reporting at least 10 cannabis sessions are feeling 38% better.

Download the Jointly app today and start accomplishing your wellness goals with cannabis and CBD!

End